This project will utilize MHealth technology to address the barriers providers and obstetric patients experience when reporting blood glucose results. Half of the participants will record their blood glucose values with the assistance of a smartphone device, the other half will continue in the traditional care method of the clinic.
This will be a prospective single center randomized trial piloting the use of mHealth applications in an obstetric population with diabetes. Participants will be enrolled in the study after the diagnosis of diabetes is made in pregnancy for those with gestational diabetes, or for patients with preexisting diabetes they will be enrolled upon initiation of prenatal care. Participants will be randomized to traditional care or mHealth intervention. Outcomes will include completeness and accuracy of the participant glucose log, unscheduled health care access episodes in the pregnancy, patient satisfaction, percentage of glucose values at goal and percent change in Hemoglobin A1C.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
21
Glucose logs will be assessed by provider for completeness and accuracy
UR Medicine Obstetrics and Gynecology
Rochester, New York, United States
Completeness and accuracy of blood glucose record
The number of values reported to the provider out of the number that should have been collected during the time period, expressed as a percent, as well as the number of values reported that were verified accurate by the meter out of the total number of values reported in the time frame expressed as a percent.
Time frame: Every 2 weeks through study completion, up to 42 weeks
Patient Satisfaction
Responses to patient satisfaction survey
Time frame: Once prior to exiting the study, an average of 42 weeks
Glucose values at goal
% of glucose values at goal during the study period
Time frame: Every 2 weeks through study completion, up to 42 weeks
% Change in Hemoglobin A1C
% of change in values of HbA1C during the study period
Time frame: Once prior to exiting the study, up to 42 weeks
Clinic visits
Number of clinic visits during the study period
Time frame: through study completion, up to 42 weeks
Unscheduled health care access episodes
Number of unanticipated or unscheduled health care visits during the study period
Time frame: through study completion, up to 42 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.